↓ Skip to main content

Growth hormone as concomitant treatment in severe fibromyalgia associated with low IGF-1 serum levels. A pilot study

Overview of attention for article published in BMC Musculoskeletal Disorders, November 2007
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

policy
1 policy source
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
37 Dimensions

Readers on

mendeley
85 Mendeley
citeulike
7 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Growth hormone as concomitant treatment in severe fibromyalgia associated with low IGF-1 serum levels. A pilot study
Published in
BMC Musculoskeletal Disorders, November 2007
DOI 10.1186/1471-2474-8-119
Pubmed ID
Authors

Guillem Cuatrecasas, Cristina Riudavets, Maria Antònia Güell, Albert Nadal

Abstract

There is evidence of functional growth hormone (GH) deficiency, expressed by means of low insulin-like growth factor 1 (IGF-1) serum levels, in a subset of fibromyalgia patients. The efficacy of GH versus placebo has been previously suggested in this population. We investigated the efficacy and safety of low dose GH as an adjunct to standard therapy in the treatment of severe, prolonged and well-treated fibromyalgia patients with low IGF-1 levels.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 85 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 2%
Brazil 1 1%
Australia 1 1%
Spain 1 1%
Greece 1 1%
Unknown 79 93%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 15 18%
Student > Master 12 14%
Researcher 10 12%
Student > Doctoral Student 7 8%
Student > Ph. D. Student 6 7%
Other 20 24%
Unknown 15 18%
Readers by discipline Count As %
Medicine and Dentistry 28 33%
Nursing and Health Professions 16 19%
Psychology 5 6%
Agricultural and Biological Sciences 3 4%
Biochemistry, Genetics and Molecular Biology 3 4%
Other 12 14%
Unknown 18 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 March 2017.
All research outputs
#4,736,890
of 22,952,268 outputs
Outputs from BMC Musculoskeletal Disorders
#974
of 4,078 outputs
Outputs of similar age
#21,775
of 156,898 outputs
Outputs of similar age from BMC Musculoskeletal Disorders
#1
of 12 outputs
Altmetric has tracked 22,952,268 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,078 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 156,898 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.